MedTrace Logo

Lifetech KONAR MFO Post-Market Clinical Follow-Up Study

NCT04417712 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-04-15

No results posted yet for this study

Summary

The purpose of the study is to collect real-world data on patient outcomes and evaluate the procedural success and performance of the Lifetech KONAR-MF™ VSD Occluder for patients with ventricular septal defect (VSD).

Conditions

  • Ventricular Septal Defect

Interventions

DEVICE

KONAR-MF™ VSD Occluder

All patients will be implanted with a KONAR-MF™ VSD Occluder in accordance with the instructions for use (IFU).

Sponsors & Collaborators

  • Lifetech Scientific (Shenzhen) Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Stephan Schubert · Heart- and Diabetescenter NRW

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-04
Primary Completion
2022-03-30
Completion
2023-06-30

Countries

  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04417712 on ClinicalTrials.gov